Download PDF
Endoskopie heute 2013; 26(4): 259-262
DOI: 10.1055/s-0033-1356204
Originalarbeit
© Georg Thieme Verlag KG Stuttgart · New York

TC-325-Applikation (Hemospray®-Device) zur endoskopischen Blutstillung bei Tumorblutungen – zwei Kasuistiken

TC-325-Application (Hemospray®-Device) For The Endoscopic Hemostasis of Malignant Bleeding Lesions – Two Case Reports
J. Binkau
,
E. Nötzel
,
D. Hartmann
Further Information

Publication History

Publication Date:
02 January 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die häufigste Indikation zur Notfallendoskopie im klinischen Alltag stellen gastrointestinale Blutungen dar. Mit der Markteinführung von Hemospray® (Cook Medical, Winston Salem, NC) im März 2013 steht eine neue Substanz zur Blutstillung nicht-variköser gastrointestinaler Blutungen im oberen Gastrointestinaltrakt zur Verfügung, die die etablierten Methoden zur Behandlung von gastrointestinalen Blutungen (Injektion, mechanische Blutstillung, thermische Verfahren) sinnvoll ergänzen kann. Wir berichten über zwei Patienten, die im Rahmen von Notfallendoskopien bei Tumorblutungen erfolgreich mit Hemospray® behandelt wurden.

Abstract

The most frequent indication in emergency endoscopy are cases with gastrointestinal bleeding. Since the introduction of Hemospray® (Cook Medical, Winston Salem, NC) in march 2013a new agent for the treatment of non-variceal bleeding in the upper gastrointestinal tract has been offered to endoscopists, which is going to amend the well-established endoscopic modalities of hemostasis (injection methods, mechanical hemostasis and thermal coagulation). We report on two patients, who were successfully treated with Hemospray undergoing emergency endoscopy because of malignant bleeding lesions.

 

  • Literatur

  • 1 Smith LA, Stanley A, Morris AJ. OC -142 Hemospray for non-variceal upper gastrointestinal bleeding: results of the SEAL Dataset (survey to evaluate the application of hemospray in the luminal tract). GUT  2012; 61: A61-A62
    PubMedGoogle Scholar
  • 2 Chen YI, Barkun AN, Soulellis C. Use of endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience. Gastroint Endosc  2012; Bd. 75 (06) 1278-1281
    PubMedGoogle Scholar
  • 3 Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med  2010; Bd. 152: 101-113
    PubMedGoogle Scholar
  • 4 Holster IL, Kuipers EJ. Management of acute nonvariceal upper gastrointestinal bleeding: Current policies and future perspectives. World J Gastroenterol 2012; 18 (11) 1202-1207
    CrossrefPubMedGoogle Scholar
  • 5 Heller SJ, Tokar JL, Ngyen MT et al. Management of bleeding GI tumors. Gastrointest Endosc 2010; 72: 817-824
    CrossrefPubMedGoogle Scholar
  • 6 Blackshaw GR, Stephens MR, Lewis WG et al. Prognostic significance of acute presentation with emergency complications of gastric cancer. Gastric cancer  2004; 7: 91-96
    PubMedGoogle Scholar
  • 7 Howell DD. The role of radiation therapy in the palliation of gastrointestinal malignancies. Acta Oncol 2008; 47: 421-427
    CrossrefPubMedGoogle Scholar
  • 8 Sung JJ, Luo D, Wu JCY et al. Early clinical experienceof the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011; 43: 291-295
    Google Scholar